VALN Investors Have Opportunity to Join Valneva SE Fraud Investigation with the Schall Law Firm

Core Viewpoint - The Schall Law Firm is investigating Valneva SE for potential violations of securities laws related to misleading statements and undisclosed information concerning its chikungunya virus vaccine, IXCHIQ [1][2]. Group 1: Investigation Details - The investigation centers on whether Valneva issued false or misleading statements or failed to disclose critical information to investors [2]. - A CDC notice dated February 25, 2025, indicates an investigation into five hospitalizations for cardiac or neurologic events following vaccination with IXCHIQ among individuals aged 65 and older [2]. - Following the CDC notice, Valneva's American Depositary Receipt (ADR) price dropped by over 13.5% in subsequent trading sessions [2]. Group 2: Legal Representation - The Schall Law Firm is representing investors globally and specializes in securities class action lawsuits and shareholder rights litigation [3]. - Shareholders who have experienced losses are encouraged to contact the firm for a free discussion of their rights [3].